Filing Details

Accession Number:
0001144204-17-032195
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-06-12 18:51:20
Reporting Period:
2017-06-09
Filing Date:
2017-06-12
Accepted Time:
2017-06-12 18:51:20
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1175151 Cytosorbents Corp CTSO Surgical & Medical Instruments & Apparatus (3841) 980373793
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1647591 G. Michael Bator C/O Cytosorbents Corp.
7 Deer Park Dr., Suite K
Monmouth Junction NJ 08852
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2017-06-09 1,500 $4.12 70,500 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. Includes (i) the following restricted stock units ("RSUs") that will be settled into common stock upon vesting upon a "Change In Control" of CytoSorbents Corporation, as defined in the CytoSorbents Corporation 2014 Long-Term Incentive Plan: (a) 6,000 RSUs granted on February 24, 2017 and (b) 60,000 RSUs granted on June 7, 2016 and (ii) 4,500 shares of common stock owned by the reporting person (including 1,500 shares of common stock purchased in the open market on June 9, 2017 and reported on this Form 4).